Status:
COMPLETED
Psychometric Properties of the Therapy-Related Symptom Checklist-Children
Lead Sponsor:
Ege University
Conditions:
Pediatric Leukemia, Acute Myeloid
Pediatric ALL
Eligibility:
All Genders
2-18 years
Brief Summary
Diagnosis and treatment of childhood cancers is an exhausting process that affects both children and their caring parents physically and mentally. While the survival rate in childhood cancers was 28% ...
Detailed Description
Leukaemias are the most common type of cancer in children and young people, accounting for 1/3 of all cancers in the population. Most childhood leukaemias are acute lymphocytic leukaemia (ALL), while ...
Eligibility Criteria
Inclusion
- The patient is between 2-18 years of age
- The patient has received chemotherapy treatment at least twice,
- The patient/caregiver parent speaks Turkish and is open to communication
- Volunteering to participate in the study.
Exclusion
- The patient is younger than 2 years of age
- The patient has never received chemotherapy
- The subject/caregiver parent does not speak Turkish
- The patient is being treated for a disease other than leukemia
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06488456
Start Date
April 1 2022
End Date
February 1 2025
Last Update
February 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ege University
Izmir, Turkey (Türkiye), 35100